Search Results - "Del Carro, U"

Painful legs and moving toes syndrome: treating movement to treat pain—a case report by Bosco, L., Falzone, Y. M., Butera, C., Bianchi, F., Vezzulli, P., Filippi, M., Del Carro, U.

Get full text

IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis by Butti, E, Bergami, A, Recchia, A, Brambilla, E, Del Carro, U, Amadio, S, Cattalini, A, Esposito, M, Stornaiuolo, A, Comi, G, Pluchino, S, Mavilio, F, Martino, G, Furlan, R

“…Central nervous system (CNS) delivery of anti-inflammatory cytokines, such as interleukin 4 (IL4), holds promise as treatment for multiple sclerosis (MS). We…”
Get full text

Going for a stroll on lurasidone: Considerations on an atypical case of acute compartment syndrome of both legs by Bosco, L., Russo, T., Falzone, Y.M., Butera, C., Del Prete, A., Mellone, R., Del Carro, U., Filippi, M., Previtali, S.C.

“…Non-traumatic acute bilateral compartment syndrome is a rare condition that may lead to limb ischemia. We describe a case of this syndrome occurring after a…”
Get full text

Metachromatic leukodystrophy - mutation analysis provides further evidence of genotype-phenotype correlation by Biffi, A, Cesani, M, Fumagalli, F, Carro, U Del, Baldoli, C, Canale, S, Gerevini, S, Amadio, S, Falautano, M, Rovelli, A, Comi, G, Roncarolo, MG, Sessa, M

“…Metachromatic leukodystrophy (MLD) is a rare lysosomal storage disorder resulting from the inherited deficiency of the arylsulfatase A (ARSA) enzyme…”
Get full text

Recommendations for the management of urinary disorders in multiple sclerosis: a consensus of the Italian Multiple Sclerosis Study Group by Ghezzi, A., Carone, R., Del Popolo, G., Amato, M. P., Bertolotto, A., Comola, M., Del Carro, U., Di Benedetto, P., Giannantoni, A., Lopes de Carvalho, M. L., Montanari, E., Patti, F., Protti, A., Rasia, S., Salonia, A., Scandellari, C., Sperli, F., Spinelli, M., Solaro, C., Uccelli, A., Zaffaroni, M., Zipoli, V.

“…Urinary disorders are uncommon in the initial phases of multiple sclerosis, but increase in frequency as the disease progresses, with a negative impact on…”
Get full text

Systemic treatment with adipose-derived mesenchymal stem cells ameliorates clinical and pathological features in the amyotrophic lateral sclerosis murine model by Marconi, S, Bonaconsa, M, Scambi, I, Squintani, G.M, Rui, W, Turano, E, Ungaro, D, D’Agostino, S, Barbieri, F, Angiari, S, Farinazzo, A, Constantin, G, Del Carro, U, Bonetti, B, Mariotti, R

“…Highlights • Administration of ASC in SOD1(G93A) mice significantly delayed motor deterioration. • Neuropathological examination revealed higher motoneurons in…”
Get full text

Design and optimization of lentiviral vectors for transfer of GALC expression in Twitcher brain by Dolcetta, D., Perani, L., Givogri, M. I., Galbiati, F., Amadio, S., Del Carro, U., Finocchiaro, G., Fanzani, A., Marchesini, S., Naldini, L., Roncarolo, M. G., Bongarzone, E.

“…Background Demyelination in globoid cell leukodystrophy (GLD) is due to a deficiency of galactocerebrosidase (GALC) activity. Up to now, in vivo brain viral…”
Get full text

Combined gene/cell therapies provide long-term and pervasive rescue of multiple pathological symptoms in a murine model of globoid cell leukodystrophy by Ricca, Alessandra, Rufo, Nicole, Ungari, Silvia, Morena, Francesco, Martino, Sabata, Kulik, Wilem, Alberizzi, Valeria, Bolino, Alessandra, Bianchi, Francesca, Del Carro, Ubaldo, Biffi, Alessandra, Gritti, Angela

“…Globoid cell leukodystrophy (GLD) is a lysosomal storage disease caused by deficient activity of β-galactocerebrosidase (GALC). The infantile forms manifest…”
Get full text

Corrigendum to “Going for a stroll on lurasidone: Considerations on an atypical case of acute compartment syndrome of both legs” [Heliyon 9(4) (April 2023) e15047] by Bosco, L., Russo, T., Falzone, Y.M., Butera, C., Del Prete, A., Mellone, R., Del Carro, U., Filippi, M., Previtali, S.C.

“…[This corrects the article DOI: 10.1016/j.heliyon.2023.e15047.]…”
Get full text

Shoulder function after selective and superselective neck dissections: clinical and functional outcomes by GIORDANO, L, SARANDRIA, D, FABIANO, B, DEL CARRO, U, BUSSI, M

“…The aim of this work is to assess the clinical and functional outcome of patients who underwent different types of neck dissection, with special regards to the…”
Get full text

Cortical activation to voluntary movement in amyotrophic lateral sclerosis is related to corticospinal damage: Electrophysiological evidence by Riva, N, Falini, A, Inuggi, A, Gonzalez-Rosa, J.J, Amadio, S, Cerri, F, Fazio, R, Del Carro, U, Comola, M, Comi, G, Leocani, L

“…Highlights ► Movement-related cortical overactivation in ALS as revealed by analysis of sensorimotor EEG rhythms occurs in the post-movement phase and not in…”
Get full text

13. Optical coherence tomography and multifocal visual evoked potential clinical usefulness in identifying visual pathway involvement by Guerrieri, S, Di Maggio, G, Vitali, F, Santangelo, R, Medaglini, S, Moiola, L, Del Carro, U, Martinelli, V, Comi, G, Leocani, L

“…Full-field visual evoked potentials (ff-VEP) are fundamental in neurological practice, for defining the nature of visual disturbances. We explored whether, in…”
Get full text

12. Sensitivity and predictive value of OCT and VEP in multiple sclerosis by Di Maggio, G, Santangelo, R, Guerrieri, S, Ferrari, L, Vitali, F, Medaglini, S, Rodegher, M, Colombo, B, Moiola, L, Del Carro, U, Martinelli, V, Comi, G, Leocani, L

“…Aim of the study was to evaluate the role of optical coherence tomography (OCT) and visual evoked potentials (VEPs) in patients with multiple sclerosis (MS),…”
Get full text

ID 275 – OCT and VEP in Multiple Sclerosis: Sensitivity and predictive value by Di Maggio, G, Santangelo, R, Guerrieri, S, Ferrari, L, Vitali, F, Medaglini, S, Rodegher, M, Colombo, B, Moiola, L, Del Carro, U, Martinelli, V, Comi, G, Leocani, L

“…To evaluate the role of optical coherence tomography (OCT) and visual evoked potentials (VEPs) in patients with multiple sclerosis (MS). Study of 121…”
Get full text

ID 338 – Retinal Nerve Fibre Layer loss is associated with disease progression in Multiple Sclerosis by Pisa, M, Di Maggio, G, Guerrieri, S, Santangelo, R, Medaglini, S, Rodegher, M, Colombo, B, Moiola, L, Del Carro, U, Martinelli, V, Comi, G, Leocani, L

“…Objective The visual pathway is receiving increasing attention as a marker to monitor and predict disability progression in Multiple Sclerosis (MS). We…”
Get full text

88. Onabotulinumtoxin-A improves chronic migraine: An open label, single-center, post-marketing prospective study by Bianchi, F, Colombo, B, Amadio, S, Guerriero, R, Butera, C, Cursi, M, Elia, P, Comi, G, Del Carro, U

“…Data from large multicenter clinical trials (PREEMPT) demonstrated efficacy and safety of onabotulinumtoxin A for prophylactic treatment of chronic migraine…”
Get full text

77. Effect of sensory tricks on brain excitability in cervical dystonia: Sensory afferent inhibition study by Butera, C, Bianchi, F, Amadio, S, Taliano, G, Urban, I.P, Guerriero, R, Cursi, M, Comi, G, Del Carro, U

“…Sensory trick (ST), i.e. the improvement of dystonic posture by application of a sensory stimulus, is a typical Cervical Dystonia (CD) feature. Though its…”
Get full text

55. VEPS and OCT in acute and chronic optic neuritis associated with multiple sclerosis by Di Maggio, G, Santangelo, R, Guerrieri, S, Ferrari, L, Medaglini, S, Rodegher, M, Colombo, B, Moiola, L, Del Carro, U, Martinelli, V, Comi, G, Leocani, L

“…To evaluate the relative value of optical coherence tomography (OCT) and visual evoked potentials (VEPs) in assessing visual involvement in patients with…”
Get full text

33. Optical coherence tomography and visual evoked potentials combined use as monitoring tools in Multiple Sclerosis patients by Guerrieri, S, Di Maggio, G, Santangelo, R, Ferrari, L, Medaglini, S, Rodegher, M, Colombo, B, Moiola, L, Del Carro, U, Martinelli, V, Comi, G, Leocani, L

“…In Multiple Sclerosis-MS, optical coherence tomography-OCT is used to measure retinal nerve fiber layer-RNFL thickness as a marker of axonal loss and visual…”
Get full text

86. Efficacy of botulinum toxin on pain and spastic gait disorders in multiple sclerosis by Guerriero, R, Amadio, S, Butera, C, Bianchi, F, Vimercati, O, Cursi, M, Martinelli-Boneschi, F, Comola, M, Comi, G, Del Carro, U

“…To assess the efficacy of botulinum toxin (BT-A) and additional physiotherapy in subjects affected by progressive multiple sclerosis (MS) with chronic lower…”
Get full text